Bioxyne inks $7m deal with NectarTek Australia by Martin Lane April 3, 2025April 3, 2025 Breathe Life Sciences (BLS) parent Bioxyne has signed a manufacturing and supply agreement with existing customer, […]
News in brief: Bioxyne raises A$3m for European expansion; cultivator’s Birchal success; Cann Group receives $750k by Steve Jones March 21, 2025March 27, 2025
Pastilles drive Bioxyne to first-half profit after revenue climbs 171% by Steve Jones March 3, 2025March 3, 2025
Bioxyne upgrades revenue forecast on back of record Q2 by Martin Lane January 24, 2025January 29, 2025
Bioxyne sees sharp revenue growth as shares jump after strong quarter by Steve Jones October 17, 2024February 25, 2025
Bioxyne forecasts doubling of revenue amid ‘$100m gummy opportunity’ by Steve Jones September 26, 2024September 26, 2024
Montu named as customer behind ‘$28m’ gummy deal as Bioxyne resumes trading on ASX by Steve Jones September 18, 2024September 19, 2024
Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne by Martin Lane and Steve Jones September 2, 2024September 3, 2024
Company news: Rua Bioscience; Avecho; Bioxyne/BLS; iX Biopharma; Ecofibre; Zelira by Steve Jones and Martin Lane August 28, 2024January 13, 2025
